ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,399.22
      -0.51%
      US Tech 100
      18,362.80
      -0.93%
      Dow Jones
      39,935.07
      0.20%
      Brent Oil
      81.665
      0.16%
      Bitcoin
      66,996.95
      1.84%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Krystal Biotech Inc (KRYS)

      7. Krystal Biotech Inc (KRYS) News

      Krystal Biotech Inc

      Krystal Biotech Inc (KRYS)

      NASDAQ
      210.69
      4.05
      (1.96%)
      Closed July 26 4:00PM
      Delayed by 15 minutes
      210.69
      -0.06
      (-0.03%)
      After Hours: 4:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      KRYS News

      Official News Only

      Form 8-K - Current report
      Edgar (US Regulatory)
      June 14 2024
      KRYS (1.96%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      May 09 2024
      KRYS (1.96%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      May 08 2024
      KRYS (1.96%)

      Form SC 13G - Statement of acquisition of beneficial ownership by individuals
      Edgar (US Regulatory)
      February 13 2024
      KRYS (1.96%)

      Form 4 - Statement of changes in beneficial ownership of securities
      Edgar (US Regulatory)
      January 09 2024
      KRYS (1.96%)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      Edgar (US Regulatory)
      November 08 2023
      KRYS (1.96%)

      Form 8-K - Current report
      Edgar (US Regulatory)
      November 07 2023
      KRYS (1.96%)

      KRYS Discussion

      View Posts
      Monksdream Monksdream 3 months ago
      KRYS 10Q due 5/6
      👍️0
      Monksdream Monksdream 4 months ago
      KRYS over $30
      👍️0
      Monksdream Monksdream 5 months ago
      KRYS new 52 week high
      👍️0
      Monksdream Monksdream 1 year ago
      From Cathie Wood
      A Novel Gene Therapy Promises Relief For A Rare Genetic Skin Disorder
      ARK Invest_Illustration_Pierce Jamieson_Final_Circle 400 px By Pierce Jamieson | @PierceARK
      Research Associate
      Recently, the US Food and Drug Administration (FDA) approved Krysta Biotech’s (KRYS) groundbreaking advance1 in gene therapy, Vyjuvek, to treat wounds in patients suffering from dystrophic epidermolysis bullosa (DEB), a rare and serious genetic skin disorder caused by mutations in the collagen Type VII alpha 1 chain (COL7A1) gene. As the first FDA-approved gene therapy for DEB, Vyjuvek is a significant breakthrough.

      Vyjuvek uses a genetically modified HSV-1 to deliver normal copies of the COL7A1 gene to wounds, restoring the integrity of the skin with fibrils that hold skin layers together. Treated with Vyjuvek, 65% of wounds closed completely.
      👍️0
      wiredawg wiredawg 3 years ago
      Moving nicely today...
      👍️0
      wiredawg wiredawg 3 years ago
      Looking at the few posts here there seems to be no real commitment here...any thoughts on KRYS? Hype or something brewing?
      👍️0
      wiredawg wiredawg 3 years ago
      In the last 3 months, 5 ranked analysts set 12-month price targets for KRYS. The average price target among the analysts is $125.00. Analysts compare their price target to the current market price of the stock to determine how much potential upside or downside movement there could be in the stock price. High $140 Low $111

      👍️0
      wiredawg wiredawg 3 years ago
      30 Nov Tues releases this PR during evening after market close:

      https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-pricing-200-million-public-offering
      👍️0
      wiredawg wiredawg 3 years ago
      29 Nov Mon after market closes release this PR:

      https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-proposed-200-million-public-offering
      👍️0
      wiredawg wiredawg 3 years ago
      29 Nov Monday pre-market news release, great move pre-market approx 7am and so far holding fairly well:

      https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-announces-positive-topline-results-gem-3-pivotal
      👍️0
      wiredawg wiredawg 3 years ago
      This caught my eye on Monday, the huge move off the PR...I'm guessing here saw the same. Any real thoughts regarding the company and this PR. I have not gotten a chance to dig into it. Hoping to have somm DD done over the weekend.
      👍️0
      wiredawg wiredawg 3 years ago
      Holding well so far, why the pretty hard drop?
      👍️0
      wiredawg wiredawg 3 years ago
      Why are you surprised? Serious question, not being impudent...
      👍️0
      rynlrt rynlrt 3 years ago
      200 million dollar offering. Won't be surprised to see it drop pretty hard when the market opens
      👍️0
      Fofo812 Fofo812 3 years ago
      Surprised it held up this long
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Large tutes holdings. Some taking huge gains before years end.
      👍️0
      rynlrt rynlrt 3 years ago
      Not sure this kind of gain is sustainable. May see a big pullback
      👍️0
      Fofo812 Fofo812 3 years ago
      3rd post
      👍️0
      crudeoil24 crudeoil24 3 years ago
      Krystal Biotech shares are trading higher after the company announced its GEM-3 trial met its primary endpoint.
      👍️0
      Trophy Trophy 5 years ago
      ..
      👍️0

      Your Recent History

      NASDAQ
      KRYS
      Krystal Biotech
      Delayed Upgrade Clock